SLEEPING SICKNESS
The DNDi & partners’ improved treatment for sleeping sickness NECT (Nifurtimox-Eflornithine Combination Therapy) has received the approval of the WHO to be placed on List of Essential Medicines (EML). More
ADVOCACY
Join the global Chagas campaign, launched on July 9th 2009 More
VISCERAL LEISHMANIASIS
At the World Congress on Leishmaniasis held on Feb. 3-7 in India, DNDi organized two symposia on ongoing clinical studies and on early-stage R&D pipeline. More than 700 attendees from around the world gathered in this event. More
CHAGAS
Join the global Chagas campaign, launched on July 9th 2009 More
MALARIA
DNDi and its partners are working to ensure access of ASAQ and ASMQ, two antimalarial fixed-dose combination therapies launched in 2007 and 2008. More
Events
2010年7月7日
長崎大学熱帯医学研究所・第33回熱帯医学研修課程にて
日本代表 平林が講演
2010年5月21日
第29回マラリア座談会にて日本代表 平林が講演
2010年5月12日
科学技術の国際連携戦略シンポジウムにてDNDi Asia代表
Dr. Navaratnamが講演を行った
DNDi GLOBAL NEWS
2010年7月7日
「New Potential TB Drugs to be Investigated Against Multiple Neglected Diseases」
引き続き原文をお読みになりたい方は こちらから
| SITEMAP | COPYRIGHT | DISCLAIMER | PRIVACY | @ 2009 DNDi All rights reserved |